<SEC-DOCUMENT>0001521036-19-000005-index.html : 20190430
<SEC-HEADER>0001521036-19-000005.hdr.sgml : 20190430
<ACCEPTANCE-DATETIME>20190430071138
ACCESSION NUMBER:		0001521036-19-000005
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190430
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20190430
DATE AS OF CHANGE:		20190430

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lantheus Holdings, Inc.
		CENTRAL INDEX KEY:			0001521036
		STANDARD INDUSTRIAL CLASSIFICATION:	IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
		IRS NUMBER:				352318913
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36569
		FILM NUMBER:		19778391

	BUSINESS ADDRESS:	
		STREET 1:		331 TREBLE COVE ROAD
		CITY:			NORTH BILLERICA
		STATE:			MA
		ZIP:			01862
		BUSINESS PHONE:		978 671-8001

	MAIL ADDRESS:	
		STREET 1:		331 TREBLE COVE ROAD
		CITY:			NORTH BILLERICA
		STATE:			MA
		ZIP:			01862

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lantheus MI Holdings, Inc.
		DATE OF NAME CHANGE:	20110517
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>a2019q1-kearnings.htm
<DESCRIPTION>8-K
<TEXT>
Document 1 - file: a2019q1-kearnings.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991q12019earningspr.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
Document 2 - file: exhibit991q12019earningspr.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lantheusa06.jpg
<TEXT>
Document 3 - file: lantheusa06.jpg

</DOCUMENT>
</SEC-DOCUMENT>